ProQuest Investments IV, L.P.

10% owner at EAGLE PHARMACEUTICALS, INC.; 10% owner at Immune Design Corp.

Sold, on record
$27.3M
Dollars the filings state
Form 4 sales
9
Latest Nov 9, 2016
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Immune Design Corp.Plan not stated
    Mar 23, 2015 2015

    Sold 44,464 shares at $27.52 ($1.2M)

    ProQuest Investments IV, L.P., 10% owner

    Sold 1.8% of holdings ($68.1M position)2.4M shares leftFiling

  2. 2 Form 4 sale Immune Design Corp.Plan not stated
    Mar 25, 2015 +2 days

    Sold 18,156 shares at $27.64 ($502k)

    ProQuest Investments IV, L.P., 10% owner

    Sold 0.7% of holdings ($67.2M position)2.4M shares leftFiling

  3. 3 Form 4 sale Immune Design Corp.Plan not stated
    Apr 7, 2015 +13 days

    Sold 7,495 shares at $26.72 ($200k)

    ProQuest Investments IV, L.P., 10% owner

    Sold 0.3% of holdings ($62.8M position)2.3M shares left0.2x usual sizeFiling

  4. 4 Form 4 sale Immune Design Corp.Plan not stated
    Apr 24, 2015 +17 days

    Sold 82,892 shares at $26.81 ($2.2M)

    ProQuest Investments IV, L.P., 10% owner

    Sold 3.7% of holdings ($60.2M position)2.2M shares left2.9x usual sizeFiling

  5. 5 Form 4 sale EAGLE PHARMACEUTICALS, INC.Unusual
    Aug 24, 2016 +488 days

    Sold 28,870 shares at $63.00 ($1.8M)

    ProQuest Investments IV, L.P., 10% owner

    Sold 48.5% of holdings ($3.8M position)30,693 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale EAGLE PHARMACEUTICALS, INC.Unusual
    Sep 21, 2016 +28 days

    Sold 99,795 shares at $66.17 ($6.6M)

    ProQuest Investments IV, L.P., 10% owner

    Sold 77.1% of holdings ($8.6M position)29,574 shares leftFiling

  7. 7 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not stated
    Sep 30, 2016 +9 days

    Sold 22,100 shares at $70.06 ($1.5M)

    ProQuest Investments IV, L.P., 10% owner

    Sold 0.5% of holdings ($308M position)4.4M shares leftFiling

  8. 8 Form 4 sale EAGLE PHARMACEUTICALS, INC.Unusual
    Nov 9, 2016 +40 days

    Sold 153,830 shares at $79.29 ($12.2M)

    ProQuest Investments IV, L.P., 10% owner

    Sold 3.7% of holdings ($328M position)4M shares left5.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by ProQuest Investments IV, L.P.
Source
Nov 9, 2016Nov 9, 2016EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale153,830$12.2M3.7%UnusualSEC
Sep 30, 2016Oct 4, 2016EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale22,100$1.5M0.5%Plan not statedSEC
Sep 21, 2016Sep 23, 2016EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale99,795$6.6M77.1%UnusualSEC
Aug 24, 2016Aug 25, 2016EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale28,870$1.8M48.5%UnusualSEC
Apr 24, 2015Apr 24, 2015Immune Design Corp.10% ownerForm 4 sale82,892$2.2M3.7%Plan not statedSEC
Apr 7, 2015Apr 8, 2015Immune Design Corp.10% ownerForm 4 sale7,495$200k0.3%Plan not statedSEC
Mar 25, 2015Mar 26, 2015Immune Design Corp.10% ownerForm 4 sale18,156$502k0.7%Plan not statedSEC
Mar 23, 2015Mar 23, 2015Immune Design Corp.10% ownerForm 4 sale44,464$1.2M1.8%Plan not statedSEC
Mar 9, 2015Mar 9, 2015Immune Design Corp.10% ownerForm 4 sale39,446$1M1.5%Plan not statedSEC